Identification, purification, and subcellular localization of prostate- specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4787-4789

  Grauer, Lana S ^a   Lawler, Kellie D ^a   Marignac, Joelle L ^a   Kumar, Abhay ^a   Goel, Amita S ^a   Wolfert, Robert L ^a  

^a Hybritech Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MESSENGER RNA; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARCINOMA CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN ANALYSIS; PROTEIN PURIFICATION;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CELL MEMBRANE; CYTOPLASM; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR WEIGHT; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032211331     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Murphy, G. P. Report on the American Urology Association/American Cancer Society Scientific Seminar on the detection and treatment of early-stage prostate cancer. CA Cancer J. Clin., 44: 91-95, 1994.
2. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., Petros, J. A., and Andriole, G. L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med., 324: 1156-1161, 1991.
3. Carter, H. B., Partin, A. W., Oesterling, J. E., Weber, J. P., Epstein, J. I., Chan, D. W., Rock, R. C., and Walsh, P. C. The use of prostate specific antigen in the management of patients with prostate cancer: the Johns Hopkins experience. In: W. J. Catalona, D. S. Coffey, and J. P. Karr (eds.), Clinical Aspects of Prostate Cancer, pp. 247-251. New York: Elsevier Scientific, 1989.
4. Horoszewicz, J. S., Kawinski, E., and Murphy, G. P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res., 7: 927-936, 1987.
5. Israeli, R. S., Powell, C. T., Fair, W. R., and Heston, W. D. W. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227-230, 1993.
6. Lopes, A. D., Davis, W. L., Rosenstraus, M. J., Uveges, A. J., and Gilman, S. C. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res., 50: 6423-6429, 1990.
7. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R., and Heston, W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.
8. Wright, G. L., Jr., Haley, C., Beckett, M. L., and Schellhammer, P. F. Expression of prostate-specific membrane antigen in normal, benign and malignant prostate tissues. Urol. Oncol., 1: 18-28, 1995.
9. Diamond, S. M., Fair, W. R., and Heston, W. D. W. Modulation of prostate specific membrane antigen (PSM) expression in vitro by cytokines and growth factors. Proc. Am. Assoc. Cancer Res., 36: 643, 1995.
10. Murphy, G., Ragde, H., Kenny, G., Barren, R., Erickson, S., Tjoa, B., Boynton, A., Holmes, E., Gilbaugh, J., and Douglas, T. Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients. Anticancer Res., 15: 1473-1480, 1995.
11. Silver, D. A., Pellicer, I., Fair, W. R., Heston, W. D. W., and Cordon-Cardo, C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res., 3: 81-85, 1997.
12. Liu, H., Moy, P., Kim, S., Xia, Y., Rajasekaran, A., Navarro, V., Knudsen, B., and Bander, N. H. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res., 57: 3629-3643, 1997.
13. 111indium-labeled monoclonal antibody CYT-356. J. Urol., 152: 1952-1955, 1994.
14. Rinker-Schaeffer, C. W., Hawkins, A. L., Su, S. L., Israeli, R. S., Griffin, C. A., Isaacs, J. T., and Heston, W. D. W. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to chromosome 11. Genomics, 30: 105-108, 1995.
15. Su, S. L., Huang, I., Fair, W. R., Powell, C. T., and Heston, W. D. W. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55: 1441-1443, 1995.
16. Troyer, J. K., Qi Feng, B. S., Beckett, M. L., and Wright, G. L. Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen. Urol. Oncol., 1: 29-37, 1995.
17. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
18. Howard, F. D., Ledbetter, J. A., Mehdi, S. Q., and Herzenberge, L. A. A rapid method for the detection of antibodies to cell surface antigens: a solid phase radioimmunoassay using cell membranes. J. Immunol. Methods, 38: 75-84, 1980.
19. Maniatis, T., Fritsch, E., and Sambook, J. Extraction, purification, and analysis of mRNA from eukaryotic cell. In: T. Maniatis, E. Fritsch, and J. Sambook (eds.), Molecular Cloning: A Laboratory Manual, pp. 188-209. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
20. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D. Basic genetic mechanisms. In: Molecular Biology of the Cell, pp. 199-253. New York: Garland Publishing, Inc., 1983.